International stocks trading in New York closed lower on Thursday.
The S&P/BNY Mellon index of American depositary receipts fell 1.2% to 152.87. The European index declined 0.7% to 144.02. The Asian index fell 1.9% to 179.83. The Latin American index fell 2.4% to 223.10. And the emerging-markets index fell 2.6% to 310.11.
Ericsson AB and Taiwan Semiconductor Manufacturing Co. were among those whose ADRs traded actively.
A booster dose of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE generated a strong immune response in children 5 to 11 years old, an encouraging sign for youngsters to maintain protection against the virus. The companies said Thursday that a late-stage study of a booster found the extra shot significantly increased antibody levels against the Omicron variant. The shot also raised antibody supply against the initial strain the vaccines were designed to fight. The booster shot was found to be safe and well-tolerated among the children in the study, the companies said. The results haven't been peer-reviewed by independent experts or published in a medical journal. BioNTech's ADRs closed 2.3% lower at $175.29.
Ericsson AB reported lower quarterly profit driven by the suspension of operations in Russia and a contract delay. The Swedish telecom-equipment maker also warned it faces a fine in the U.S. related to its handling of a corruption scandal in Iraq. The Justice Department has said the company's handling of the matter violated the terms of a 2019 settlement. ADRs fell 9% to $8.49.
Taiwan Semiconductor Manufacturing Co., the world's largest contract chip maker, signaled that the global chip shortage was likely to continue, with tight production capacity for all types of chips it makes. TSMC expects manufacturers to stock up more than usual on chips and other components after recent events disrupted the global supply chain, Chief Executive C.C. Wei said on a quarterly earnings call. ADRs fell 3.1% to $98.36.
-- WSJ staff
(END) Dow Jones Newswires
04-14-22 1640ET
